Tesla Registrations Rise in Five European Markets During May
New Tesla vehicle registrations increased in Denmark, Spain, Sweden, Norway, and France in May compared with the same month a year earlier. Data released by local industry groups showed gains ranging from 29 percent to more than seven times prior levels.
investors.comTesla vehicle registrations rose in five European countries during May, according to figures released by local industry groups and reported by Reuters. Denmark recorded 1,750 new registrations, an increase of 136 percent from a year earlier. Spain posted 1,690 registrations, up 113 percent, while Sweden reached 858 registrations, a 71 percent gain.
Norway registered 3,345 Tesla vehicles, a 29 percent increase, and France recorded 5,446 registrations, more than seven times the total from May 2025.
Battery-electric, plug-in hybrid, and hybrid vehicles accounted for more than two-thirds of all new registrations across Europe in April, with total electrified vehicle registrations rising about 21 percent, according to ACEA. The company had lost market share in Europe during 2025 amid increased competition and a limited product refresh cycle.
Transparency
Reported by a single outlet. This score reflects source tier and factual specificity — corroboration is limited with one source.
Story details
Related Stories
thehindu.comU.S. Strikes Botswana-Flagged Tanker in International Waters; Iran Blockade in Effect
A U.S. aircraft fired an AGM-114 Hellfire missile into the engine room of the M/T Lexie on Tuesday, disabling the unladen vessel as it headed toward Kharg Island. The strike followed repeated ignored warnings over 24 hours.
prnewswire.comFed Chairman Names Two Outside Advisers During Transition
Federal Reserve Chairman Kevin Warsh appointed two interim advisers shortly after taking the post. One previously contributed to a conservative plan calling for major changes at the central bank.
insidermonkey.comForte Biosciences Accepts Resignation of Director David Veitch
Forte Biosciences disclosed the resignation of independent director David Veitch from its board effective June 1 2026. The departure reduces the company's board size and triggers standard SEC and Nasdaq disclosure obligations for director changes at the clinical-stage biopharmace…